Mike Hennessy Jr, President and CEO

The treatment landscape for multiple myeloma continues to evolve.

The authors of these peer -reviewed papers collectively emphasize the evolving landscape of oncology treatment.

MJH Life Sciences is celebrating its 25th anniversary.

Pharmacists will play an integral role in this evolving field, from patient education and monitoring AEs to new therapeutic developments and treatment protocols.

The 2024 American Society. ofClinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, highlighted significant advancements across various oncology disciplines.

AI has been everywhere for the past several years, and its impact is finally being seen in pharmacy.

Rapid advancements in technology over the past several decades have brought significant benefits to health care systems.

Since 1997, Pharmacy Times has compiled these results to collect the most up-to-date information about which brands pharmacists recommend most often to patients.

Drug shortages, such as the shortages of cisplatin and carboplatin in 2023, have significantly affected oncology.

As pharmacists continue to step into additional roles, culturally competent care becomes an even more essential part of their practices.

These developments highlight the dynamic landscape of health care innovation and the collaborative efforts driving progress in disease management and treatment.

The impact pharmacist-led research on oncology pharmacy practice in the field of oncology is undeniable.

Opill is a nonprescription, progestin-only contraceptive pill, with nearly 50 years of use and data supporting the safety and effectiveness of progestin-only pills.